advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse

Project description

Enhancing screening in the drug discovery pipeline will boost successful passage through it

Drug approval still takes about 14 years and the failure rate during clinical trials is about 85 %. At each phase, many targets fail due to safety and efficacy issues, in large part because research models of disease do not adequately model all human factors. SINERGIA will focus on optimising the use of four cutting-edge technologies that support in vivo modelling of drug mechanisms and effects. It brings together academic research entities, contract research organisations, and biotech and pharmaceutical companies. Implementation of better disease models in the drug discovery pipeline could significantly enhance the success and speed at which new candidates are brought from the bench to the bedside.

Fields of science

• medical and health sciences › medical biotechnology › cells technologies › stem cells
• medical and health sciences › medical biotechnology › tissue engineering
• medical and health sciences › basic medicine › physiology

Programme(s)

• H2020-EU.1.3.1. - Fostering new skills by means of excellent initial training of researchers

Topic(s)

• MSCA-ITN-2019 - Innovative Training Networks

Call for proposal

H2020-MSCA-ITN-2019
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

POLITECNICO DI MILANO

Address

Piazza Leonardo Da Vinci 32
20133 Milano
Italy

Activity type

Higher or Secondary Education Establishments

EU contribution

€ 522 999,36

Participants (9)

UNIVERSITAT BASEL

Switzerland

EU contribution

€ 562 553,28

Address

Petersplatz 1
4051 Basel

Activity type

Higher or Secondary Education Establishments

UNIVERSITEIT MAASTRICHT

Netherlands

EU contribution

€ 531 239,76

Address

Minderbroedersberg 4
6200 MD Maastricht

Activity type

Higher or Secondary Education Establishments

FAKULTNI NEMOCNICE U SV. ANNY V BRNE

Czechia

EU contribution

€ 469 743,12

Address

Pekarska 53
656 91 Brno

Activity type

Higher or Secondary Education Establishments

UNIVERSITAETSKLINIKUM AACHEN

Germany

EU contribution

€ 252 788,40

Address

Pauwelsstrasse 30
52074 Aachen

Activity type

Higher or Secondary Education Establishments

Ente Ospedaliero Cantonale

Switzerland

EU contribution

€ 562 553,28

Address

Vialle Officina 3
CH-6500 Bellinzona

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

ACCELERA SRL

Italy

EU contribution

€ 261 499,68

Address

Viale Pasteur 10
20014 Nerviano Mi

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

LIFETEC GROUP BV

Netherlands

EU contribution

€ 265 619,88

Address

Kennedyplein 11
5611 ZS Eindhoven

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

BIOMIMX SRL

Italy

EU contribution

€ 261 499,68

Address

Via Giovanni Durando 38/A
20158 Milano

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

MTTLAB SRL

Italy

EU contribution

€ 261 499,68

Address

Via Giacinto Gallina 5
34132 Trieste

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)